Lanean...
Effects of liraglutide and empagliflozin added to insulin therapy in patients with type 2 diabetes: A randomized controlled study
AIMS/INTRODUCTION: Liraglutide and empagliflozin suppress cardiovascular events. However, reports on their long‐term combined use with insulin therapy or direct comparisons of these drugs are limited. MATERIALS AND METHODS: This open‐label, parallel‐group, randomized controlled trial compared the ef...
Gorde:
| Argitaratua izan da: | J Diabetes Investig |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7610130/ https://ncbi.nlm.nih.gov/pubmed/32279451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13270 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|